Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
Susanna C Larsson1,2, Matthew Traylor2, Rainer Malik3
1Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden susanna.larsson@ki.se.
Higher educational attainment is linked to a lower risk of Alzheimer's disease. This study explored various modifiable factors, finding education to be a significant protective element against Alzheimer's disease.
Area of Science:
- Neuroscience and Genetics
- Public Health and Epidemiology
Background:
- Alzheimer's disease (AD) poses a significant global health challenge.
- Identifying modifiable risk factors is crucial for AD prevention strategies.
Purpose of the Study:
- To investigate associations between potentially modifiable risk factors and Alzheimer's disease.
- To determine the impact of socioeconomic, lifestyle, cardiometabolic, and inflammatory factors on AD risk.
Main Methods:
- Employed a Mendelian randomization study design.
- Utilized genetic variants as instrumental variables for modifiable risk factors.
- Analyzed data from the International Genomics of Alzheimer's Project (17,008 AD cases, 37,154 controls).
Main Results:
- Genetically predicted educational attainment showed a significant association with reduced Alzheimer's disease risk.
- Suggestive evidence indicated potential protective associations for smoking and 25-hydroxyvitamin D levels.
- Higher coffee consumption was suggestively associated with an increased risk of Alzheimer's disease.
Conclusions:
- Higher educational attainment is associated with a reduced risk of Alzheimer's disease.
- Further research into lifestyle factors like smoking, vitamin D, and coffee consumption may offer new avenues for AD prevention.
More Related Videos
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
